Rowena Brook
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes.
Journal: Journal of thrombosis and thrombolysis
Published: February 07, 2025
Global coagulation assays for patients with diabetes and their utility in the prediction of atherothrombotic events.
Journal: Blood vessels, thrombosis & hemostasis
Published: January 30, 2025
Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk.
Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk.
Journal: Research and practice in thrombosis and haemostasis
Published: April 21, 2024
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients.
Journal: Journal of thrombosis and thrombolysis
Published: July 17, 2022
The Need for Individualized Risk Assessment in Cardiovascular Disease.
Journal: Journal of personalized medicine
Published: June 13, 2022
The evaluation of overall hemostatic potential assay in patients with COVID-19 infection.
Journal: International journal of laboratory hematology
Published: November 11, 2021
Risk factors and early prediction of clinical deterioration and mortality in adult COVID-19 inpatients: an Australian tertiary hospital experience.
Journal: Internal medicine journal
Published: June 13, 2021
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.
Journal: BMJ case reports
Published: July 11, 2020
Real-world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk.
Journal: Internal medicine journal
Published: June 06, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026